What can falsely raise calprotectin?

Calprotectin is a stool marker that signals neutrophil-driven inflammation in the gut, and it is widely used to help differentiate inflammatory bowel disease from non-inflammatory conditions. But calprotectin can rise for reasons other than chronic inflammatory disease, which can confuse diagnosis and delay appropriate care. In this guide, you’ll learn what calprotectin is, how it’s used, and the many factors that can falsely elevate results. You’ll also see why symptoms alone rarely reveal the full story, how the gut microbiome can influence inflammation, and when deeper investigation—such as microbiome testing—may help clarify what your numbers really mean.

Core Explanation of Calprotectin and Its Diagnostic Role

What is calprotectin? Calprotectin is a protein complex (S100A8/S100A9) abundant in neutrophils, a type of white blood cell. When the intestinal lining becomes inflamed, neutrophils migrate into the gut lumen and release calprotectin. Because calprotectin remains stable in stool for several days, it serves as a practical, noninvasive marker of intestinal inflammation.

How is calprotectin used? Clinicians commonly use fecal calprotectin to help distinguish inflammatory bowel disease (IBD) from functional gastrointestinal disorders such as irritable bowel syndrome (IBS). Lower values often suggest a non-inflammatory condition; moderate to markedly elevated values increase the likelihood of inflammation. While cut-offs vary by lab and clinical context, many use ranges such as:

• Low/normal: typically below 50 μg/g (adult reference ranges vary)
• Borderline/indeterminate: approximately 50–150/200 μg/g
• Elevated: above 150–200 μg/g
• Markedly elevated: above 500–600 μg/g (more strongly suggests active inflammatory disease)

Conditions linked to elevated calprotectin: Fecal calprotectin can rise in IBD (Crohn’s disease, ulcerative colitis), infectious gastroenteritis, diverticulitis, microscopic colitis, celiac disease (especially if untreated), colorectal neoplasia, ischemic colitis, and after significant mucosal injury. It may also increase transiently after gastrointestinal procedures that disturb the mucosa.

Clinical significance: The test is valuable because it detects inflammation without bloodwork or invasive procedures. Still, it is neither disease-specific nor fully predictive of severity. Clinicians interpret calprotectin alongside history, symptoms, imaging, endoscopy, and other biomarkers.

Why This Topic Matters for Gut Health

An accurate understanding of gut inflammation guides the next steps in care. If calprotectin is high because of a transient or non-inflammatory factor, intensifying IBD therapy or moving quickly to invasive procedures may not be warranted. Conversely, ignoring a persistently high result may delay needed evaluation. Symptoms like abdominal pain, diarrhea, and bloating overlap across many conditions, which is why calprotectin is helpful—but also why false positives matter. Recognizing the full range of causes for elevated values helps patients and clinicians decide when to repeat testing, when to look for alternate explanations, and when to consider broader assessments, including the gut microbiome.

Recognizing Symptoms, Signals, and Health Implications

Common symptoms of gut inflammation: Diarrhea (sometimes with blood or mucus), abdominal cramping, urgency, nocturnal stools, weight loss, fever, and fatigue can accompany inflammatory processes. However, these signs are not exclusive to IBD or infection, and their intensity does not always match the degree of measurable inflammation.

Non-inflammatory symptom patterns: Gas, bloating, abdominal discomfort relieved by defecation, diet-triggered symptoms (e.g., with high-FODMAP foods), and stable weight often point to functional gut disorders or dysbiosis rather than classic mucosal inflammation. Still, some individuals with IBS-like symptoms can show low-grade immune activation or altered barrier function, complicating interpretation.

Clinical implications of falsely elevated calprotectin: A spurious rise can lead to unnecessary anxiety, additional procedures, or incorrect assumptions about disease activity. On the other hand, under-recognized contributors—like recent medications or a passing infection—can make a borderline test appear more ominous than it is. A careful clinical history and thoughtful follow-up (including repeat calprotectin) are central to accurate evaluation.

Individual Variability and Uncertainty in Calprotectin Testing

Calprotectin values fluctuate for biological and practical reasons. Day-to-day variation occurs, and values can change with stool consistency, sampling location within the same stool, and assay method. Baseline ranges are not uniform across all ages; infants and toddlers often have higher normal values due to developing immunity and rapid microbiome changes. Older adults can also have slightly higher baselines, influenced by comorbidities and medications. Athletes who exercise intensely may show transient increases related to gut stress. Understanding these sources of variability helps avoid over-interpreting a single measurement.

External influences—like recent gastrointestinal infections, NSAID use, bowel preparation, and endoscopic procedures—can temporarily elevate calprotectin. Pre-analytical factors, including sample handling and storage, can also impact results, though calprotectin is relatively stable compared to many biomarkers. When results conflict with the clinical picture, repeating the test after removing potential confounders often clarifies the signal.

Why Symptoms Alone Do Not Reveal the Root Cause

Many gastrointestinal symptoms—pain, bloating, stool frequency changes—are shared by inflammatory conditions, functional disorders, food intolerances, and microbiome imbalances. Because of this overlap, relying on symptoms alone can lead to false assumptions. For instance, severe cramping and diarrhea could reflect foodborne illness, IBS-D, bile acid malabsorption, or active IBD. Without objective markers like calprotectin and complementary data such as stool cultures, celiac serology, or microbiome profiles, it’s hard to discern the underlying driver. Objective testing does not replace clinical judgment, but it helps separate inflammatory pathology from other processes that may feel similar day to day.

The Role of the Gut Microbiome in Calprotectin Levels

The gut microbiome—trillions of bacteria, fungi, viruses, and archaea—supports digestion, nutrient production, immune training, and barrier integrity. Microbial metabolites such as short-chain fatty acids (SCFAs) help maintain the mucosal barrier and regulate inflammatory signaling. When this ecosystem becomes imbalanced (dysbiosis), pattern-recognition receptors on intestinal cells and immune cells may be overstimulated, triggering or perpetuating low-grade inflammation. This can, in some people, nudge calprotectin upwards into a borderline range even without overt IBD.

Dysbiosis is not a diagnosis by itself, but a state in which protective commensals (e.g., several butyrate producers) are reduced and potential pathobionts (e.g., some Proteobacteria) expand. This altered ecology can contribute to barrier dysfunction (“leaky gut”), immune activation, and symptom sensitivity. In such settings, calprotectin may reflect a biologically meaningful but non-diagnostic signal that calls for deeper context rather than immediate escalation to anti-inflammatory therapy.

How Microbiome Imbalances May Contribute to Elevated Calprotectin

Microbial dysbiosis and low-grade inflammation: Certain microbial patterns correlate with increased epithelial stress and immune activation. Reduced SCFA producers may impair barrier support, while expansions in endotoxin-producing Gram-negative bacteria can stimulate neutrophil recruitment. The result can be a modest bump in fecal calprotectin, especially during symptom flares or dietary triggers, even without classic IBD.

About “calprotectin cross-reactivity” and false positives: Immunoassays for calprotectin are designed to be specific for human S100A8/A9. They generally do not cross-react with microbial proteins. What can occur, however, is a biological “false positive” situation—where microbial products (like lipopolysaccharides) activate neutrophils and mucosal immunity, increasing true calprotectin release in the absence of chronic inflammatory disease. The distinction matters: the assay is measuring calprotectin accurately, but the underlying cause is not necessarily IBD.

Non-inflammatory factors influencing calprotectin: Not all elevations reflect sustained, tissue-damaging inflammation. Acute infections, strenuous exercise, recent mucosal irritation, or medication effects can transiently increase neutrophil activity. Dietary shifts that strongly alter microbiota composition can also change mucosal signaling. In these scenarios, values often normalize once the trigger resolves.

Specific Causes of Falsely Elevated Calprotectin

1) Infections and Post-Infectious States

Acute bacterial gastroenteritis (e.g., Campylobacter, Salmonella, Shigella), Clostridioides difficile, and some parasitic infections (e.g., Giardia) commonly raise calprotectin. Viral infections can elevate it to a lesser degree. Importantly, calprotectin may remain elevated for several weeks after symptoms improve due to ongoing mucosal recovery. In a post-infectious state, a single elevated value may look concerning even if the main illness has passed. Repeat testing after 2–6 weeks can help determine whether the elevation was transient.

2) Medication Effects

• NSAIDs and aspirin: These drugs can irritate the gastrointestinal lining and increase intestinal permeability, resulting in elevated calprotectin in some users. Athletes who combine NSAIDs with endurance exercise may be especially susceptible.
• Proton pump inhibitors (PPIs): Some studies—particularly in children—have reported modestly higher fecal calprotectin among PPI users, possibly due to changes in microbial composition or small-intestinal inflammation. Data in adults are mixed, and effects may vary.
• Other agents: Certain chemotherapeutics, mycophenolate, and drugs linked to microscopic colitis can be associated with increased calprotectin due to mucosal inflammation. Antibiotics may either reduce or increase calprotectin transiently by altering the microbiome or by treating an undiagnosed infection.

3) Recent Gastrointestinal Procedures or Trauma

Endoscopy with mucosal biopsies, polypectomy, bowel preparation, and surgical interventions can temporarily raise calprotectin. The degree and duration depend on the extent of mucosal disturbance. If your test was collected shortly after a procedure, a repeat after healing (1–4 weeks) can provide a cleaner baseline.

4) Age and Baseline Physiology

Infants and toddlers often show higher normal fecal calprotectin levels due to immune maturation and rapid shifts in the microbiome. Older adults may have slightly higher baselines influenced by comorbidities and polypharmacy. Age-appropriate reference ranges matter, and values should be interpreted relative to clinical context rather than absolute numbers alone.

5) Strenuous Endurance Exercise

Prolonged, intense exercise can temporarily increase intestinal permeability, alter splanchnic blood flow, and promote mild mucosal stress. Studies in endurance athletes have reported transient calprotectin elevations after marathons or ultra-events. Typically, values normalize with rest and adequate hydration/nutrition, but the immediate post-event window is not ideal for baseline assessment.

6) Non-IBD Inflammatory Conditions

Microscopic colitis, diverticulitis, ischemic colitis, and eosinophilic colitis can elevate calprotectin in ways that mimic IBD signals. Celiac disease, particularly when untreated or during gluten exposure, may increase calprotectin; levels often decline with mucosal healing. Colorectal neoplasia (cancer and some advanced adenomas) can also be associated with elevated fecal calprotectin, which is one reason an unexplained, persistently high value warrants medical follow-up.

Autoevaluación en 2 minutos ¿Es útil para ti un test del microbioma intestinal? Responde a unas pocas preguntas rápidas y descubre si un test del microbioma es realmente útil para ti. ✔ Solo toma 2 minutos ✔ Basado en tus síntomas y estilo de vida ✔ Recomendación clara sí/no Comprobar si el test es adecuado para mí →

7) Bleeding and Sample Contamination

Visible rectal bleeding from hemorrhoids or fissures does not always raise calprotectin significantly, but heavy bleeding or contamination with menstrual blood may affect results. Most stool collection instructions recommend avoiding sampling during active menstruation or immediately after rectal bleeding. If bleeding was present, inform your clinician and consider repeating the test once resolved.

8) Diet, Alcohol, and Lifestyle

Short-term dietary changes can influence the microbiome and, in sensitive individuals, nudge calprotectin upward. Heavy alcohol use may contribute to mucosal irritation and barrier dysfunction, potentially affecting calprotectin. Food intolerances (e.g., high-FODMAP triggers) primarily cause symptoms via fermentation and motility changes rather than frank inflammation, but individuals vary widely; some experience low-grade immune activation.

9) Sample Handling and Analytical Variability

Although fecal calprotectin is relatively stable at room temperature for several days (depending on assay), pre-analytical issues can still occur. Extremely watery stools can challenge extraction methods, leading to variability. Different labs use different immunoassays and cutoffs, which may yield slightly different results on the same sample. When a result seems out of step with clinical reality, repeating the test with standardized handling and, if feasible, the same assay can reduce uncertainty.

Why Symptoms Alone Do Not Reveal the Root Cause

Two people can have identical symptoms but different underlying causes—one with post-infectious IBS and a transiently raised calprotectin, another with active IBD requiring closer monitoring. Conversely, some people with elevated calprotectin feel relatively well, while others with substantial distress show low values and a functional disorder. Because subjective experiences map poorly onto specific biological pathways, symptom-based diagnosis can miss key mechanisms like dysbiosis, bile acid disturbances, microscopic colitis, or low-grade infection. Objective tools—calprotectin among them—bring needed clarity, but they still benefit from complementary evaluation to identify the true drivers.

The Benefits of Microbiome Testing in the Context of Elevated Calprotectin

When calprotectin results are borderline or surprising, microbiome testing can add context by revealing patterns that support or challenge an inflammatory explanation. For example, lower diversity with expansion of potential pathobionts may point to dysbiosis-related immune activation rather than classic IBD. Conversely, a community rich in SCFA producers might suggest that another factor—like a recent infection or medication effect—is a more likely culprit for a transient bump.

Microbiome analysis can highlight:

• Diversity and stability: Lower diversity is often associated with inflammatory and metabolic risk states.
• Beneficial metabolite producers: Abundance of butyrate-producing taxa and other commensals that support the mucosal barrier.
• Potential pathobionts and opportunists: Elevated Proteobacteria or specific species that may provoke immune responses.
• Ecological imbalances: Shifts that correlate with symptoms (bloating, irregular stools) even when overt inflammation is absent.

If you are exploring whether hidden imbalances might be contributing to symptoms or borderline inflammation signals, an at-home microbiome test can offer educational insights that complement medical evaluation. It is not a diagnostic in itself but can inform a more personalized understanding of your gut ecosystem.

How Microbiome Insights Can Differentiate Inflammatory vs. Microbiome-Driven Elevations

While no single microbiome pattern “diagnoses” inflammation, a profile dominated by dysbiosis-related shifts may align with low-grade immune activation and symptom sensitivity rather than severe mucosal injury. In that case, a modestly elevated calprotectin could be secondary to ecological stressors, recent dietary shifts, or a resolving infection. If a microbiome profile appears relatively balanced, attention may turn to other contributors: medications (e.g., NSAIDs), recent procedures, or a need for repeat testing to confirm persistence.

Integrating microbiome data with calprotectin trends can help frame next steps: If calprotectin remains high and symptoms suggest significant inflammation, medical evaluation is indicated regardless of microbiome results. If calprotectin is borderline and microbiome findings point to reversible imbalances, clinicians and patients might prioritize non-invasive strategies, careful monitoring, and a timed retest.

Who Should Consider Microbiome Testing?

• People with inconsistent or borderline calprotectin results: Especially if values fluctuate around the threshold where decisions get difficult.
• Individuals with symptoms but no clear inflammatory diagnosis: Bloating, irregular stools, food sensitivities, or post-infectious changes.
• Those with recurrent or unexplained gastrointestinal issues: Cyclical flares without a definitive diagnosis can reflect dynamic microbiome states.
• Patients evaluating inflammatory vs. non-inflammatory causes: Microbiome data can provide additional ecological context for nuanced choices.

For readers seeking a structured view of their gut ecology, the InnerBuddies microbiome test offers an accessible way to explore diversity, potential imbalances, and patterns linked with symptoms, to be reviewed alongside clinical care.

Decision-Support: When Does Testing Make Sense?

Recognize the limits of calprotectin alone: While exceptionally useful, calprotectin is an inflammation signal without disease specificity. Strong elevations typically warrant clinical evaluation, but borderline results often benefit from context and repeat measurement.

Situations where combining tests helps:

• Recent infections, NSAID use, or procedures that might transiently elevate values
• Persistent symptoms with borderline calprotectin and unclear etiology
• Cases where imaging or endoscopy is deferred but more clarity is needed
• Monitoring recovery after a known trigger (e.g., gastroenteritis) to confirm normalization

Role of microbiome insights: A microbiome profile can highlight hidden imbalances that do not show up on routine labs but still influence symptoms and low-grade immune activity. This can prevent premature conclusions, support rational timing of repeat calprotectin, and inform conversation with your clinician about next steps. If this added perspective would be helpful, consider reviewing your ecosystem with a trusted microbiome analysis used for educational insight.

Interpreting Calprotectin Numbers in Real Life

Borderline or mildly elevated (about 50–200 μg/g): Consider recent triggers (infection, NSAIDs, endurance exercise, procedures). Review medications, symptoms, and timing. Many clinicians repeat the test in 2–6 weeks and correlate with stool studies or other markers if symptoms persist.

Moderately elevated (about 200–500 μg/g): Increases the likelihood of inflammatory disease or significant irritation. Combined with red flags (weight loss, nocturnal diarrhea, blood in stool), this often prompts further evaluation. If obvious confounders exist, a short-interval retest can still be informative.

Markedly elevated (>500–600 μg/g): More strongly associated with active inflammatory conditions. Urgent evaluation is typically warranted, though the exact threshold and urgency depend on the clinical picture and lab standards.

Cut-offs vary, and age-specific reference ranges matter—especially in infants and older adults. Always interpret values within the broader clinical context rather than in isolation.

Practical Steps Before and After a Calprotectin Test

• Timing: Avoid sampling immediately after invasive procedures, acute gastroenteritis, or endurance events if you need a baseline.
• Medications: Discuss NSAIDs and other potentially irritating drugs with your clinician before testing.
• Collection: Follow kit instructions carefully; avoid collecting during active menstruation or immediately after rectal bleeding.
• Repeat if needed: If results are borderline or unexpected, a repeat test after removing confounders often clarifies the trend.
• Contextual data: Consider stool cultures, celiac serology, or microbiome analysis when indicated to better understand discrepant findings.

Understanding the Biology: Why Calprotectin Rises

Calprotectin is released as neutrophils migrate into the gut lumen in response to chemokines and danger signals. It binds calcium and zinc, helping to sequester metal ions from microbes—a part of the immune system’s antimicrobial defense. High fecal levels therefore reflect active neutrophil traffic at the mucosal surface. This can occur during frank inflammation (as in IBD) or transiently when the barrier is stressed (e.g., after a bacterial infection or heavy exertion). The protein’s stability in stool makes it reliable for transport and testing, but also means short-lived spikes can still be captured several days after a trigger.

Common Pitfalls and How to Avoid Misinterpretation

• Assuming every elevation equals IBD: Infections, medications, and procedures are frequent reasons for transiently high values.
• Overlooking borderline results: Indeterminate values deserve follow-up but not overreaction. Trends over time are more informative than a single data point.
• Ignoring age and context: Pediatric and geriatric baselines differ; symptoms, diet, and comorbidities matter.
• Neglecting the microbiome: Dysbiosis can contribute to low-grade inflammation and symptom sensitivity, influencing values without classic disease.
• Relying on symptoms alone: Shared symptom patterns can mask very different underlying mechanisms.

Putting It All Together: From Signal to Insight

Calprotectin is a powerful signal of neutrophil activity at the gut lining, but it is one piece of a larger puzzle. When values are unexpectedly high, consider timing (recent illnesses or exertion), medications (especially NSAIDs), and procedures. If results are borderline or inconsistent with how you feel, repeating the test and adding context—stool studies, dietary review, and microbiome profiling—may help differentiate transient triggers from ongoing inflammatory processes. The goal is not to chase numbers but to understand what they are signaling in your specific biology.

Key Takeaways

• Calprotectin measures neutrophil-driven intestinal inflammation but is not disease-specific.
• False or transient elevations are common with infections, NSAIDs, endurance exercise, and recent procedures.
• Age, stool consistency, assay differences, and sampling technique introduce variability.
• Symptoms alone cannot distinguish inflammatory from non-inflammatory gut conditions.
• Dysbiosis can contribute to low-grade immune activation and modest calprotectin rises.
• Repeat testing after removing confounders is often appropriate for borderline results.
• Consider complementary tests (stool cultures, celiac serology) when the picture is unclear.
• Microbiome testing can reveal ecological patterns that contextualize calprotectin results.
• Persistently high values with red flags warrant medical evaluation.
• Personalized interpretation—over time and in context—leads to better decisions.

Q&A: What People Often Ask About Calprotectin

Can stress alone raise calprotectin?

Psychological stress can influence gut motility, sensitivity, and barrier function, but its direct effect on fecal calprotectin is inconsistent and generally modest. If stress coexists with other triggers (e.g., poor sleep, dietary changes), small increases may occur, but large, sustained elevations usually indicate additional factors.

Do NSAIDs really increase fecal calprotectin?

Yes, NSAIDs can irritate the GI mucosa and increase intestinal permeability, leading to higher calprotectin in some individuals. The effect is often reversible; if clinically appropriate, retesting after a period off NSAIDs can clarify whether they contributed to the elevation.

How long after a GI infection should I wait to retest?

Because calprotectin can stay elevated during mucosal healing, many clinicians wait 2–6 weeks after symptom resolution before repeating. The optimal timing depends on severity, ongoing symptoms, and clinical judgment.

Autoevaluación en 2 minutos ¿Es útil para ti un test del microbioma intestinal? Responde a unas pocas preguntas rápidas y descubre si un test del microbioma es realmente útil para ti. ✔ Solo toma 2 minutos ✔ Basado en tus síntomas y estilo de vida ✔ Recomendación clara sí/no Comprobar si el test es adecuado para mí →

Does menstruation affect the test?

Menstrual blood can potentially contaminate a stool sample and influence results. It’s generally recommended to avoid collection during active menstruation and to follow instructions carefully to minimize contamination.

Can vigorous exercise elevate calprotectin?

Endurance events and strenuous exercise can transiently increase intestinal permeability and mild mucosal stress, sometimes raising calprotectin. If you need a baseline measurement, avoid heavy exertion in the days leading up to sample collection.

Are infants’ calprotectin levels naturally higher?

Yes. Infants and toddlers commonly have higher baseline calprotectin due to immune maturation and rapid microbiome development. Age-appropriate reference ranges and clinical context are essential when interpreting pediatric results.

Could celiac disease cause elevated calprotectin?

Active celiac disease can raise calprotectin, particularly with ongoing gluten exposure, as the small intestine becomes inflamed. Values may decline with effective dietary management and mucosal healing, though clinical follow-up is important.

Does a normal calprotectin rule out IBD?

Low calprotectin makes active IBD less likely, especially in the colon, but does not fully exclude it. Small-bowel-predominant disease or early/mild inflammation can sometimes present with lower values. Clinical evaluation guides next steps when suspicion remains.

Can the microbiome test diagnose IBD?

No. Microbiome testing is an educational tool that describes community patterns and potential imbalances; it does not diagnose disease. However, it can provide context for symptoms and inflammation markers, informing discussions with your clinician.

Should I repeat calprotectin if my result was borderline?

Often, yes. If the value was borderline or unexpected, and there were potential confounders (e.g., recent infection, NSAID use), repeating the test after 2–6 weeks can clarify whether the elevation persists. Decisions depend on symptoms, risk factors, and clinical advice.

Do PPIs affect calprotectin?

Some studies, particularly in children, have shown modest associations between PPI use and higher calprotectin, possibly through microbiota changes or small-intestinal effects. Evidence in adults is mixed. If results are unclear, discuss timing and medications with your clinician.

Could hemorrhoids cause a false positive?

Minor hemorrhoidal bleeding does not necessarily raise calprotectin substantially, but heavy bleeding or sample contamination can affect the test. If bleeding was present at collection, inform your clinician and consider retesting once it resolves.

Concluding: Connecting the Dots — Understanding Your Unique Gut Microbiome

Calprotectin is an invaluable signal for detecting intestinal inflammation, but it is not a stand-alone diagnosis. Elevations may be transient, medication-related, or reflect low-grade immune activation in the context of microbiome imbalance. Symptoms, too, are helpful but not definitive. By combining objective markers with ecological insight from your gut microbiome, you can move beyond guesswork and toward a more personalized understanding of what drives your digestive health. When the picture is murky—borderline values, shifting symptoms, or uncertain triggers—adding microbiome context and carefully timed repeat testing can turn a confusing signal into a clearer path forward.

Keywords

calprotectin, falsely elevated calprotectin levels, calprotectin false positives, causes of elevated calprotectin, calprotectin cross-reactivity, non-inflammatory factors affecting calprotectin, gut microbiome, dysbiosis, stool inflammation marker, neutrophils, intestinal barrier, NSAIDs and calprotectin, infections and calprotectin, endurance exercise gut, microscopic colitis, celiac disease, colorectal neoplasia, personalized gut health, microbiome testing